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One Answer for All?*
Eike Nagel, MD, PHD,y Valentina O. Puntmann, MD, PHDzSEE PAGE 27M yocardial T1 mapping by cardiac magneticresonance (CMR) is not just very fashion-able; increasingly, T1 mapping provides
original answers to many pertinent clinical questions.
Initially, T1 mapping was seen as a potential means of
improved quantitative assessment of ischemic scar,
allowing escape from the “black and white” binary,
qualitative deﬁnition by late gadolinium enhance-
ment (LGE) (1). However, absolute quantiﬁcation on
a voxel-wise level requires not only a clinically robust
and artifact-free sequence, allowing reproducible
measurements between users, transferability
between centers, and translatability between ﬁeld
strengths and vendors (2,3), but also reliable normal-
ization of segmental values and sufﬁciently high
spatial resolution to determine the epicardial to sub-
endocardial transmurality of a myocardial infarction
(4). Due to these requirements, the original aim
remains still largely unattained, and LGE persists as
the robust and well-validated tool for assessment of
ischemic scar despite its limitations. A series of unex-
pected discoveries, however, revealed the previously
unforeseen strengths of T1 mapping, the greatest of
which is that native contrast agent–free T1 mapping,
on the basis of modiﬁed Look-Locker sequences
(MOLLI) is able to detect, characterize, and*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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Native T1 mapping allows detection of diffuse
myocardial ﬁbrosis in various cardiomyopathies (5),
inﬂammation (e.g., in myocarditis) (6), or inﬁltration
(e.g., amyloidosis) (7), as well as an approximation
of ischemic myocardial scar (4), sometimes superior
to contrast-enhanced techniques, such as LGE, post-
contrast T1 mapping, and measurement of extracel-
lular volume fraction. This phenomenon can to a
great extent be explained by the inherent sensitivity
of MOLLI sequences to detect water (also known as
T2 dependency), a predominant constituent of hu-
man myocardium. It is important to realize that
various T1-mapping sequences have a different sensi-
tivity to water, explaining some of the discrepancies
in the reported observations (8,9). The amount of
myocardial water can increase due to a variety of un-
derlying reasons such as altered cell size, increased
interstitial space, and, as to the focus of this editorial,
increased myocardial blood volume.In this issue of iJACC, Liu et al. (10) report on
myocardial native T1 at rest and adenosine stress
using a shortened modiﬁed Look-Locker sequence
(shMOLLI) (5[1]1[1]1 MOLLI) variant (11). The most
intriguing ﬁnding is an increased T1 at rest in
myocardial segments subtended by a hemodynami-
cally signiﬁcant coronary artery. During adenosine
stimulation, native T1 remains unchanged in these
segments, whereas in healthy subjects a 6% increase
in native T1 during vasodilation is found. Infarct
tissue has the highest T1 at rest and shows no
response to adenosine, and remote myocardium in
patients with coronary artery disease demonstrates
normal T1 at rest with a reduced adenosine response
compared with controls.
The authors explain these observations by changes
in myocardial blood volume, which may provide the
basis for an interesting concept of contrast-free and
potentially stress-free ischemia testing, on the basis
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38of the differential T1 proﬁles assessing a variety of
pathophysiological alterations. This crucial concept
of myocardial pathophysiology is on the basis of a
number of previous observations and has been
explored by various imaging methods (Figure 1).
In the normal myocardium, coronary blood volume
takes up 6% to 15% of its mass. Approximately 36% of
this blood is contained in the myriads of small
microvascular vessels <200 mm in diameter. When
epicardial coronary resistance increases, such as with
a signiﬁcant coronary artery stenosis, the large mesh
of microvasculature distal to the stenosis (resistance
vessels) dilates in compensation to keep total
vascular resistance (and thus blood ﬂow) stable.
Consequently, resting blood volume in this area in-
creases signiﬁcantly. This phenomenon of auto-
regulation forms the basis for assessing the presence
and signiﬁcance of coronary artery stenoses at rest by
measuring myocardial blood volume with a number
of techniques. Using contrast echocardiography, the
amount of microbubbles in the myocardium corre-
lates linearly with myocardial blood volume (12).
Unfortunately, this effect is counteracted by
increased ﬂow, reducing its diagnostic power in
clinical practice (13). With CMR, it is possible to detectFIGURE 1 Schematic Illustration of BOLD and T1 Mapping for
the Detection of Coronary Artery Disease
Schematic illustration of a myocardial segment at rest (top row)
and adenosine stress (bottom row) for a healthy control (N) (left)
as well as a patient with a signiﬁcant coronary artery disease
(CAD) (right). In CAD, the microvasculature is dilated at rest to
compensate for the increased resistance of the epicardial coronary
artery. This leads to a larger blood volume (red dots) and a larger
amount of deoxyhemoglobin (blue dots). A similar vasodilation of
the microvasculature can be achieved in controls with adenosine
stress. In patients with CAD, no further change is induced. T1
mapping will pick up the increased blood volume and thus show
increased T1 signal in CAD at rest, but no further change during
stress. Similarly, blood oxygen level dependent techniques will
pick up the amount of deoxyhemoglobin and show a reduced T2*
signal in CAD at rest with no further change during stress.abnormal resting myocardial blood volume with
blood oxygen level dependent (BOLD) techniques.
The BOLD T2* signal is mainly determined by the
amount of deoxygenated hemoglobin, which changes
in a given voxel in parallel to the amount of blood.
A higher blood volume increases the amount of
deoxygenated hemoglobin, which consequently re-
duces the observed T2* signal (14).
The concept underlying the study by Liu et al. (10)
is very interesting. A contrast- and stress-free test for
the assessment of myocardial ischemia would be a
leap forward in the work-up of patients with sus-
pected coronary artery disease. However, a long list
of caveats remains. This is an observation in a pilot
study of 20 controls done at different ﬁeld strengths
and 10 patients. The concept needs to be proved in a
clinically realistic and more complex setup and vali-
dated in appropriate numbers of patients. The effect
size is small (6% change in healthy controls) and may
be below the natural variability within less selected
patients. Previous other concepts of contrast-free or
stress-free perfusion imaging, including spin labeling
or BOLD imaging as discussed previously have not
made a signiﬁcant clinical impact to date. A plethora
of additional effects from parameters such as ﬂow,
hematocrit, oxygenation, and tissue homogeneity
may inﬂuence the results. The results obtained with
shMOLLI may not be translatable to other T1-mapping
techniques and may require the use of different
techniques within 1 examination to answer different
questions. Most importantly, an objective quantita-
tive measurement of the severity of ischemia is
required to understand whether the underlying
pathology is clinically signiﬁcant. Ultimately, any
diagnostic test needs to inﬂuence clinical manage-
ment, and its use must improve outcome. The long
road of clinical translation lies ahead.
Native T1 mapping has already shown its effec-
tiveness in its ability to differentiate between normal
and abnormal myocardium. If it can also provide
quantitative information on the presence, extent, and
severity of myocardial ischemia, it has the potential
to evolve as the one imaging parameter to inform
most of the relevant clinical questions rapidly, at rest
and without the need for contrast agents, and support
clinical management beyond the capacity of present
clinical tools.
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